Goldilocks and the three bonds: New evidence for the conditional benefits of dietary α-linolenic acid in treating cardiovascular risk in the metabolic syndrome

British Journal of Nutrition

Volumn 108, Issue 4, 2012, Pages 579-580

  Griffin, Bruce A ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANOLA OIL; CARBOHYDRATE; CHOLESTEROL; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LONG CHAIN FATTY ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; OLIVE OIL; OMEGA 3 FATTY ACID; RAPESEED OIL; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ABDOMINAL FAT; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FAT INTAKE; GLYCEMIC INDEX; HEART PROTECTION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID COMPOSITION; LOW FAT DIET; METABOLIC DISORDER; METABOLIC SYNDROME X; NOTE; PRIMARY PREVENTION; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ALPHA-LINOLENIC ACID; BRASSICA RAPA; CARDIOVASCULAR DISEASES; DIET, REDUCING; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PLANT OILS; WEIGHT LOSS;

EID: 84865252711     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002887     Document Type: Note

References (12)

1. Baxheinrich A, Stratmann B, Lee-Barkey YH, et al. (2012) Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of a-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br J Nutr 108, 682-691.
2. Tierney AC, McMonagle J, Shaw DI, et al. (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome - LIPGENE: a European randomized dietary intervention study. Int J Obes 35, 800-809.
3. Jebb SA, Lovegrove JA, Griffin BA, et al. (2010) Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 92, 748-758.
4. Mozaffarian D & Wu JHY (2011) Omega-3 fatty acids and cardiovascular disease. J Am Coll Cardiol 58, 2047-2067.
5. von Schacky C (2012) Omega-3 fatty acids: anti-arrhythmic, pro-arrhythmic or both? Front Physiol 3, 1-11.
6. Givens DI & Gibbs RA (2008) Current intakes of EPA and DHA in European populations and the potential of animalderived foods to increase them. Proc Nutr Soc 67, 273-280.
7. Griffin BA (2008) How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Op Lipidol 19, 57-62.
8. Burdge GC & Calder PC (2005) Conversion of a-linolenic acid to longer chain polyunsaturated fatty acids in adult human adults. Reprod Nutr Dev 45, 581-597. (Pubitemid 41511883)
9. Hussein N, Ah-Sing E, Wilkinson P, et al. (2005) Long-chain conversion of [13C]-linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 46, 269-280. (Pubitemid 40271091)
10. Liu JC, Conklin SM, Manuck SB, et al. (2011) Long-chain omega-3 fatty acids and blood pressure. Am J Hypertens 24, 1121-1126.
11. Paschos G, Magkos F, Panagiotakos DB, et al. (2007) Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 61, 1201-1206. (Pubitemid 47521552)
12. Gibson RA, Neumann MA, Lien EL, et al. (2012) Docosahexaenoic acid synthesis from alpha-linolenic acid is inhibited by diets high in polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids (Epublication ahead of print version 17 April 2012).